Skip to content

TriSalus Life Sciences, Inc.

TLSI TLSIW

CIK 0001826667

← back to feed
Revenue (TTM)
$40.85M
+53.4% YoY Q1 May 2026
Net Income (TTM)
−$27.94M
−30.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.59
−40.5% YoY Q1 May 2026
Gross Margin
84.3%
Q1 May 2026
Operating Margin
-78.6%
Q1 May 2026
Net Margin
-68.4%
Q1 May 2026
Free Cash Flow (TTM)
−$33.32M
Q1 May 2026
Cash
$56.55M
Q1 May 2026
Total Debt
$33.08M
Q1 May 2026
Shares Outstanding
61.42M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings